Browsing by Subject "Còlon -- Càncer"
Now showing items 1-11 of 11
-
Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study
(2018)Background: The phase III RAISE trial (NCT01183780) demonstrated that the vascular endothelial growth factor (VEGF) receptor (VEGFR)-2 binding monoclonal antibody ramucirumab plus 5-fluororuracil, ... -
Copy number variations of colorectal cancer by whole exome sequencing data
(2014-09)Colorectal cancer (CRC) is the third most common cancer and the fourth leading cause of cancer death worldwide. About 85% of the cases of CRC are known to have chromosomal instability, an allelic ... -
Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E-mutant metastatic colorectal cancer: Updated survival results and subgroup analyses from the BEACON study
(2021)PURPOSE BEACON CRC evaluated encorafenib plus cetuximab with or without binimetinib versus investigators' choice of irinotecan or FOLFIRI plus cetuximab in patients with BRAF V600E-mutant metastatic ... -
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
(2019)Colorectal cancers with BRAF mutations have an aggressive natural history and are often resistant to therapy. A treatment regimen that combined BRAF inhibition, MET inhibition, and blocking of EGFR ... -
Estratègies de prevenció en la incidència del càncer de còlon
(2024-04)Introducció: El càncer de còlon és el tercer càncer més diagnosticat mundialment, suposant així, un problema social. Es tracta d'una malaltia idiopàtica, per tant, la seva prevenció és crucial. Objectiu: ... -
Faecal microrna and colorectal cancer in symptomatic patients: a case-control study
(2024-05-15)ABSTRACT Colorectal cancer (CRC) screening program is performed with fecal occult blood test (FOBT) in asymptomatic patients between 50 and 69 years of age. It has been shown to be effective in ... -
Identification of chromosomal rearrangements in colorectal cancer
(2015-09)Cancer research is continuously shedding light into these worldwide leading diseases. It is mandatory to have higher knowledge in cancer biology to consequently find out new candidate biomarkers and ... -
Impact of the covid-19 pandemic in staging and mid-term survival of colorectal cancer: a retrospective view
(2024-05-21)RESUMEN La pandemia por COVID-19 se ha asociado a una disminución en la incidencia de cáncer colorrectal (CRC) debido a la irrupción de los programas de cribado y al desbordamiento del sistema ... -
Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines
(2021)Colorectal cancer (CRC) is still a leading cause of cancer-related deaths in the United States and worldwide, despite recent improvements in cancer management. CRC, like many malignancies, is a ... -
Multidisciplinary approach for the study of the lipid metabolism in colon cancer
(2021-09)Colorectal cancer is a leading cause of cancer death worldwide, its late detection contributes for become one of the deadliest. Research team of Lipids in Human Pathology has proven a relationship ...